← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3295)
- Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. A novel anti-CD47 protein antibody and toll-like receptor agonist complex detects tumor surface CD-47 changes in early stage lung cancer by in vivo imaging. (2024/08/01) ♡
- The association of nutritional and inflammatory biomarkers with overall survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors. (2024/08/01) ♡
- The influence of nutritional status, lipid profile, leptin concentration and polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of immunotherapy in advanced NSCLC patients. (2024/08/01) ♡
- Cytotoxicity of Benzofuran-Containing Simplified Viniferin Analogues. (2024/08/01) ♡
- Predictive value of inflammation and nutritional index in immunotherapy for stage IV non-small cell lung cancer and model construction. (2024/07/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advanced Lung Cancer Inflammation Index: A Novel Comprehensive Biomarker of Host Status for Patients with Metastatic Colorectal Cancer. (2024/07/30) ♡
- Using the combined C-reactive protein and controlling nutritional status index for elderly non-small cell lung cancer. (2024/07/30) ♡
- Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience. (2024/07/30) ♡
- Living with low muscle mass and its impact throughout curative treatment for lung cancer: A qualitative study. (2024/07/29) ♡
- Plain language summary of a clinical study: anamorelin for treatment of Japanese people with non-small cell lung cancer and cachexia. (2024/07/29) ♡
- Psychiatric Comorbidities and Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer. (2024/07/29) ♡
- Utility of PET for Nodal Staging in Subsolid Clinical Stage IA (T1 N0) Lung Adenocarcinoma. (2024/07/26) ♡
- A new classification of upper gastrointestinal toxicity induced by immunotherapy: from endoscopic and pathological insights to clinical management. (2024/07/25) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy. (2024/07/25) ♡
- Dynamics of peripheral blood inflammatory index predict tumor pathological response and survival among patients with locally advanced non-small cell lung cancer who underwent neoadjuvant immunochemotherapy: a multi-cohort retrospective study. (2024/07/23) ♡
- Topotecan in a Real-World Small-Cell Lung Cancer Cohort: Prognostic Biomarkers Improve Selection of Patients for Second-Line Treatment. (2024/07/19) ♡
- Integrated network pharmacology and metabolomics to reveal the mechanism of Pinellia ternata inhibiting non-small cell lung cancer cells. (2024/07/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy. (2024/07/11) ♡
- Analysis of risk factors of postoperative complication for non-small cell lung cancer. (2024/07/10) ♡
- Pain and Coping Strategies as Determinants of Malnutrition Risk in Lung Cancer Patients: A Cross-Sectional Study. (2024/07/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Overcoming Chemoresistance in Cancer: The Promise of Crizotinib. (2024/07/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epithelial-mesenchymal transition (EMT) and its role in acquired epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) chemoresistance in non-small cell lung cancer (NSCLC). (2024/07/06) ♡
- Geriatric Nutritional Risk Index as a Prognostic Marker for Elderly Patients With Small Cell Lung Cancer. (2024/07/03) ♡
- Oral administration of oligo fucoidan improves the survival rate, quality of life, and immunity in patients with lung cancer. (2024/07/03) ♡
- Splice-switching antisense oligonucleotide controlling tumor suppressor REST is a novel therapeutic medicine for neuroendocrine cancer. (2024/07/02) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Electrolyte disorders in oncological patients]. (2024/07/01) ♡
- Role of circulating microRNAs in non-small cell lung carcinoma. (2024/07/01) ♡
- Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway. (2024/07/01) ♡
- Integrative oncology for patients with lung cancer: A prospective pragmatic controlled trial. (2024/07/01) ♡
- Biologically Interpretable Model for Precise Recurrence Prediction of Non-Small Cell Lung Cancer. (2024/07/01) ♡
- Development of a Multiscale Mechanistic Model for Predicting Tumor Response to Anti-miR-155. (2024/07/01) ♡
- Hard example mining in Multi-Instance Learning for Whole-Slide Image Classification. (2024/07/01) ♡
- Knowledge Models for Cancer Clinical Practice Guidelines: Construction, Management, and Usage in Question Answering. (2024/07/01) ♡
- A novel inflammatory nutrient index for predicting survival outcomes in patients with non-small cell lung cancer. (2024/06/30) ♡
- Network pharmacology analysis, molecular docking integrated experimental verification reveal β-sitosterol as the active anti-NSCLC ingredient of Polygonatum cyrtonema Hua by suppression of PI3K/Akt/HIF-1α signaling pathway. (2024/06/28) ♡
- Highly Sensitive 3D Nanoplasmonic-Based Epidermal Growth Factor Receptor Mutation Multiplex Assay Chip for Liquid Biopsy. (2024/06/26) ♡
- Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy. (2024/06/25) ♡
- Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer. (2024/06/24) ♡
- Circulating tumor DNA kinetics: A future tool for radiation therapy personalization in lung cancer? (2024/06/21) ♡
- Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report. (2024/06/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Bayesian network meta-analysis of EGFR-tyrosine kinase inhibitor treatments in patients with EGFR mutation-positive non-small cell lung cancer. (2024/06/21) ♡
- The survival and cost-effectiveness analysis of adjunctive Chinese medicine therapy for patients with non-small cell lung cancer: a nationwide cohort study in Taiwan. (2024/06/20) ♡
- Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome. (2024/06/20) ♡
- Values of a novel comprehensive prognostic nutritional index (FIDA) in the prognosis of non-small cell lung cancer. (2024/06/20) ♡
- Value of prognostic nutritional index and controlling nutritional status score for advanced non-small cell lung cancer patients receiving PD-1 inhibitors. (2024/06/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Long-term, 13-year survival after immune cell therapy combined with chemotherapy for extensive-stage small-cell lung cancer: a case report. (2024/06/14) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Green Seaweed Caulerpa racemosa as a Novel Non-Small Cell Lung Cancer Inhibitor in Overcoming Tyrosine Kinase Inhibitor Resistance: An Analysis Employing Network Pharmacology, Molecular Docking, and In Vitro Research. (2024/06/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Twenty-five years with HER2 targeted therapy. (2024/06/10) ♡
- A stability indicating method development and validation of a rapid and sensitive RP-HPLC method for Nintedanib and its application in quantification of nanostructured lipid carriers. (2024/06/10) ♡
- Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti-PD‑1 inhibitors based on the absolute counts of lymphocyte subsets. (2024/06/04) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.